Sydney Sarcoma Unit

Research Project Main Image

Project main description:

The Sydney Sarcoma Unit is a multidisciplinary unit providing the best possible care for patients with soft tissue sarcoma. The unit comprises surgeons, radiation oncologists, medical oncologists, radiologists, pathologists, scientists, statisticians and nurses experienced in the treatment of this rare tumour. As well as providing definitive care, we provide physicans and patients with information about the diagnosis and management of soft tissue tumours, both benign and malignant.

The Sydney Sarcoma Unit meets every week to discuss and plan treatment for patients with soft tissue tumours.

As well as providing a clinical service to patients, the SSU is actively involved in finding better ways for treating sarcomas through both clinical and basic research.

What is sarcoma?

Soft tissue sarcoma is a rare cancer that can arise in many different tissues including muscles, fat and fascia. These tumours commonly occur in the the limbs but can also occur in the retroperitoneum (posterior part of the abdomen) and other parts of the chest and abdomen. They can also arise in the gastrointestinal tract (eg stomach) and uterus. Sarcomas can also occur in bone, particularly in children. These tumours are treated very differently to the more common soft tissue sarcoma. For more information about bone sarcoma please refer to other sites. Like most cancers, sarcoma is best treated by a team of cancer specialists with experience in dealing with this disease, particularly sarcoma which is an uncommon cancer.

For more information, please check:

Adult Soft tissue Sarcoma - information for health professionals

What is sarcoma? - Information from the Memorial Sloan Kettering Cancer Center

Information about what is sarcoma, staging of sarcoma and treatment options from the National Cancer Institute

Australian Sarcoma Study Group

Research

SSU has a basic research focus on identifying genes that are important in cancer initiation, development and metastasis in particular soft tissue sarcomas. We are evaluating the significance of genetic variations which we hope will enable us to better predict patient outcome. We are also investigating new genetic targets for sarcoma treatment; as well as enhancing the sensitivity of cancers to radio-/chemo-therapy via regulating gene expression. All these studies will have an important clinical impact on diagnosis and treatment of sarcomas and other cancers.Clinical studiesconcentrate on analysis of clinicopathological prognostic factors and testing new treatment modalities.

Current

Collaboration

Donations

Postgraduate

Publications

SSU Doctors

If you wish to arrange a consultation with a specific SSU consultant please contact one of the following physicians:

Surgeons:
Prof Phil Crowe - Director Sydney Sarcoma Clinic: 02 9382 2894
Dr Andrew Parasyn: 02 9382 2900

Radiation Oncologists:
Dr Stephen Thompson: 02 9382 2563
A/Prof Robert Smee: 02 9382 2533

Medical Oncologists:
Prof Micheal Friedlander: 02 9382 2586
Dr Craig Lewis: 02 9382 2606

Scientist and Statistics Consultant:
A/Prof Jia Lin Yang: 02 9382 3331

Contact Information

Telephone: +61-2-9382 2894; FAX: +61-2-9382 2670

Email: p.crowe@unsw.edu.au

Postal address: Department of Surgery, Prince of Wales Hospital, Sydney 2031, Australia